Morgan Stanley lowered the target price for Trad Chi Med (00570) to HKD4.9 from HKD5.4 and maintained the "overweight" rating.
The research house said following a centralized procurement price cut in 1H24 and in view of recent monthly trends, it cuts 2024-2030 earnings by 10-14% on lower formula granule sales and gross margins.
《說說心理話》【奧運劍擊熱】大師兄張小倫親身分享!贏在起跑線=壓力?如何培育子女有卓越成就?► 即睇